HT Vet

Company Overview

Snapshot

Founded in January 2021 by Gideon Barak and Shani Toledano, HT Vet operates with 11–50 employees. The company has raised $1 million across two funding rounds, with NextLeap Ventures participating. In May 2026, HT Vet secured a grant from the BIRD Foundation.

Business overview

HT Vet develops an AI-driven solution for the early diagnosis of cancer in pets, specifically focusing on dogs. The company's core product, HT Vista, is an AI-driven non-invasive screening tool that enables veterinarians and nurses to rule out dermal and subcutaneous masses as cancerous. Utilizing its unique Heat Diffusion Imaging (HDI) technology and cloud-based analysis, HT Vista allows for on-the-spot cancer screening within veterinary practices. HT Vet operates in the Health Tech & Life Sciences sector, serving the veterinary industry and pet owners.

Strategic signal

In January 2026, HT Vet's Vista IQ introduced a new cancer diagnostic service, which is projected to unlock $130,000 in annual revenue for veterinary clinics. This development signals a significant advancement in the commercialization and market penetration of HT Vet's AI-driven diagnostic tools, demonstrating clear value proposition and revenue generation potential for its veterinary partners.

Company Intelligence Q&A

What is HT Vet's primary focus?

HT Vet focuses on developing AI-driven non-invasive screening tools for the early diagnosis of cancer in pets, particularly dogs.

When was HT Vet founded and by whom?

HT Vet was founded in January 2021 by Gideon Barak and Shani Toledano.

What is the HT Vista device?

The HT Vista device is an AI-driven non-invasive screening tool that allows veterinarians and nurses to rule out cancer in dermal and subcutaneous masses in dogs using Heat Diffusion Imaging (HDI) technology and cloud-based analysis.

Has HT Vet received any recent grants?

In May 2026, HT Vet secured a grant from the BIRD Foundation.

What significant product development did HT Vet announce in early 2026?

In January 2026, HT Vet's Vista IQ introduced a new cancer diagnostic service, which is expected to generate $130,000 in annual revenue for veterinary clinics.